Golgi staining of a mouse brain done by Tao Lin of the NRI Neuropathology Core and imaged by Biochemistry student Quynh Nguyen. Quynh is studying how TMEM106B determines the balance between neuronal resilience and vulnerability in Alzheimer's and other dementias.
Join the Lab!
We are recruiting several postdoctoral fellows and research technicians to work on exciting new projects in gene therapy, aging, and amyloid heterogeneity. View postings and apply.
Understanding Alzheimer's Disease One Mouse at a Time
Our research focuses on the pathogenesis of Alzheimer’s disease. Broadly speaking, we want to understand factors which influence disease risk and that dictate the stereotyped loss of neural circuits needed for memory. More specifically, we want to understand how aging increases the likelihood of dementia, how genetics may influence this risk, and how specific brain areas are selectively affected.
Our laboratory uses transgenic mice as a model system that can be engineered to reproduce focused aspects of the disease. These models allow us to test cellular and molecular hypotheses about causes and consequences of disease pathology, and to define how interactions between genes, environment, and aging determine resilience or risk.
We are currently pursuing three avenues of study. One project explores the genetic basis of cognitive reserve by engineering mice to express a gene variant associated with preserved cognition in patients with Alzheimer's neuropathology. Complementary studies examine how brain aging contributes to Alzheimer's risk using mice designed to stop time through exogenous control of amyloid onset. Finally, we are investigating the basis for progressive neuronal vulnerability in Alzheimer's using mice created to test whether circuit function contributes to disease susceptibility. Our hope is that mice and men share sufficient similarities in genetic architecture, basic physiology, and neuronal circuitry to gain insight from one useful in understanding the other.
Key Research Questions
- What is the molecular basis for Alzheimer’s disease? How does a small peptide like Aβ lead to the devastating cognitive decline of AD? What accounts for the decade of lag time between the start of Aβ accumulation and the onset of memory complaints?
- How do genetics influence whether individuals with amyloid pathology progress to dementia or remain cognitively healthy?
- How does aging contribute to AD? Why does this disease primarily strike late in life?
- What makes neurons of the entorhinal cortex particularly vulnerable in AD? Might their normal role in episodic memory contribute to their frailty in disease?
